A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...

After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they ...

Why some health groups are banding together to push for a range of obesity-care options in workplace-sponsored insurance.

Roche moved to enter the booming weight-loss drug market now dominated by Novo Nordisk and Eli Lilly. The Swiss ...

Compounding pharmacies will have to stop producing copycats of tirzepatide, the active ingredient in the blockbuster weight ...

New trial data showed CagriSema led to “superior” weight loss, but at a rate much less than original expectations of 25%.

Novo Nordisk on Monday revealed weaker-than-expected data from a second late-stage trial of its obesity drug candidate ...

The U.S. Food and Drug Administration said on Monday it will not take action against compounding pharmacies making copies of ...

Typically when a new drug comes on the market, physicians are conservative about their prescribing habits, but this has not ...

Very few people are currently being prescribed drugs for weight loss on the NHS in Scotland, research by BBC Scotland News ...

Weight loss drugs like tirzepatide and semaglutide are growing in popularity and offer significant health benefits, but they ...

Novo Nordisk said on Monday its experimental next-generation drug CagriSema helped overweight or obese patients with type 2 ...